{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT03266653",
            "orgStudyIdInfo": {
                "id": "NYMC 581"
            },
            "secondaryIdInfos": [
                {
                    "id": "FD006363",
                    "type": "OTHER_GRANT",
                    "domain": "FDA OOPD"
                }
            ],
            "organization": {
                "fullName": "New York Medical College",
                "class": "OTHER"
            },
            "briefTitle": "EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection",
            "officialTitle": "A Pilot Study in the Treatment of Refractory Epstein-Barr Virus (EBV) Infection With Related Donor EBV Cytotoxic T-Lymphocytes in Children, Adolescents and Young Adult Recipients",
            "therapeuticArea": [
                "Infectious Diseases",
                "Immunology and Rheumatology"
            ],
            "study": "ebv-specific-cytotoxic-t-lymphocytes-ctls-for-refractory-ebv-infection"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-05",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2020-07-07",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-08-31",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-12-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2017-08-25",
            "studyFirstSubmitQcDate": "2017-08-28",
            "studyFirstPostDateStruct": {
                "date": "2017-08-30",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-05-15",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-17",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Mitchell Cairo",
                "investigatorTitle": "Principal Investigator",
                "investigatorAffiliation": "New York Medical College"
            },
            "leadSponsor": {
                "name": "New York Medical College",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "Children's Hospital of Philadelphia",
                    "class": "OTHER"
                },
                {
                    "name": "Medical College of Wisconsin",
                    "class": "OTHER"
                },
                {
                    "name": "Nationwide Children's Hospital",
                    "class": "OTHER"
                },
                {
                    "name": "Indiana University",
                    "class": "OTHER"
                },
                {
                    "name": "Washington University School of Medicine",
                    "class": "OTHER"
                },
                {
                    "name": "University of California, Los Angeles",
                    "class": "OTHER"
                },
                {
                    "name": "University of California, San Francisco",
                    "class": "OTHER"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "Related donor Epstein-Barr Virus (EBV) specific cytotoxic T cells (CTLs) manufactured with the Miltenyi CliniMACS Prodigy Cytokine Capture System will be administered in children, adolescents and young adults with refractory EBV infection post Allogeneic Hematopoietic Stem Cell Transplantation (AlloHSCT), with primary immunodeficiencies (PID) or post solid organ transplant.\n\nFunding Source: FDA OOPD"
        },
        "conditionsModule": {
            "conditions": [
                "Epstein-Barr Virus Infections",
                "Primary Immune Deficiency Disorder"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "interventionModelDescription": "All patients given identical treatment with CTLs for refractory EBV.",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 20,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Refractory EBV",
                    "type": "EXPERIMENTAL",
                    "description": "Patients with refractory EBV will get one dose of EBV specific CTLs. If they don't show a response based on EBV PCRs, patients may get up to another 4 doses of EBV-CTLs (5 doses maximum)",
                    "interventionNames": [
                        "Drug: cytotoxic t-lymphocytes"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "cytotoxic t-lymphocytes",
                    "description": "EBV specific CTLs will be generated from HLA related matched and mismatched donors in a GMP facility and administered to the patient with refractory CTLs.",
                    "armGroupLabels": [
                        "Refractory EBV"
                    ],
                    "otherNames": [
                        "CTLs"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Incidence of Treatment-Emergent Adverse Events [Safety and Tolerability]",
                    "description": "Patients will be monitored for adverse events related to the infusion of EBV CTLs",
                    "timeFrame": "Patients will be followed for 12 weeks after each infusion"
                },
                {
                    "measure": "Incidence of Response to Treatment [Efficacy]",
                    "description": "Patients will be followed for improvement in viral infection by monitoring EBV PCR weekly for response to treatment with CTLs",
                    "timeFrame": "Patients will be followed for 12 weeks after each infusion"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "1. Patients with Epstein-Barr virus infections post allogeneic HSCT, primary immunodeficiencies or post solid organ transplant with:\n\n* Increasing or persistent quantitative EBV RT-PCR DNA copies despite two weeks of appropriate anti-viral therapy and/or\n* progressive clinical symptoms attributable to EBV, including biopsy proven colitis, lymphadenopathy, hepatomegaly, splenomegaly AND/OR\n* Medical intolerance to anti-viral therapies including:\n* intolerance to rituximab Consent: Written informed consent given (by patient or legal representative) prior to any study-related procedures.\n\nPerformance Status \\> 30% (Lansky \\< 16 yrs and Karnofsky \\> 16 yrs) Age: 0.1 to 79.99 years Females of childbearing potential with a negative urine pregnancy test\n\n2 Donor Eligibility 5.2.1 Related donor available with a T-cell response to the EBV MACS\u00ae GMP PepTivator antigen(s) causing the therapy-refractory EBV infection.\n\na. Third Party Related Allogeneic Donor: If original donor is not available or does not have a T-cell response: third party related allogeneic donor (family donor \\> 1 HLA A, B, DR match to recipient) with IgG positive to EBV and/or a T-cell response at least to the viral MACS\u00ae GMP PepTivator EBV Select (containing among other antigens, NA-1, LMP2A and BZLF-1).\n\nAND Allogeneic donor disease screening is complete similar to hematopoietic stem cell donors (Appendix 1).\n\nAND Obtained informed consents by donor or donor legally authorized representative prior to donor collection.\n\n3 Patient exclusion criteria:\n\nA patient meeting any of the following criteria is not eligible for the present study:\n\nPatient with acute GVHD \\> grade 2 or extensive chronic GVHD at the time of CTL infusion Patient receiving steroids (\\>0.5 mg/kg prednisone equivalent) at the time of CTL infusion Patient treated with donor lymphocyte infusion (DLI) within 4 weeks prior to CTL infusion Patient with poor performance status determined by Karnofsky (patients \\>16 years) or Lansky (patients \u226416 years) score \u226430% Concomitant enrollment in another experimental clinical trial investigating the treatment of refractory EBV infection Any medical condition which could compromise participation in the study according to the investigator's assessment Known HIV infection Female patient of childbearing age who is pregnant or breast-feeding or not willing to use an effective method of birth control during study treatment.\n\nKnown hypersensitivity to iron dextran Patients unwilling or unable to comply with the protocol or unable to give informed consent.\n\nKnown human anti-mouse antibodies",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "1 Month",
            "maximumAge": "79 Years",
            "stdAges": [
                "CHILD",
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Mitchell Cairo, MD",
                    "role": "CONTACT",
                    "phone": "914-594-2150",
                    "email": "mitchell_cairo@nymc.edu"
                },
                {
                    "name": "Lauren Harrison",
                    "role": "CONTACT",
                    "phone": "6172857844",
                    "email": "lauren_harrison@nymc.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Mitchell Cairo, MD",
                    "affiliation": "New York Medical College",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Children's Hosptial Los Angeles",
                    "status": "RECRUITING",
                    "city": "Los Angeles",
                    "state": "California",
                    "zip": "90027",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Neena Kapoor, MD",
                            "role": "CONTACT",
                            "email": "nkapoor@chla.usc.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.05223,
                        "lon": -118.24368
                    }
                },
                {
                    "facility": "University of California San Francisco",
                    "status": "RECRUITING",
                    "city": "San Francisco",
                    "state": "California",
                    "zip": "94158",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Julia Chu, MD",
                            "role": "CONTACT",
                            "email": "Julia.Chu2@ucsf.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.77493,
                        "lon": -122.41942
                    }
                },
                {
                    "facility": "Johns Hopkins",
                    "status": "RECRUITING",
                    "city": "Baltimore",
                    "state": "Maryland",
                    "zip": "21287",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Kenneth Cooke, MD",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.29038,
                        "lon": -76.61219
                    }
                },
                {
                    "facility": "Washington University",
                    "status": "RECRUITING",
                    "city": "Saint Louis",
                    "state": "Missouri",
                    "zip": "63130",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Shalini Shenoy, MD",
                            "role": "CONTACT",
                            "email": "shalinishenoy@wustl.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.62727,
                        "lon": -90.19789
                    }
                },
                {
                    "facility": "New York Medical College",
                    "status": "RECRUITING",
                    "city": "Valhalla",
                    "state": "New York",
                    "zip": "10595",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Mitchell S Cairo, MD",
                            "role": "CONTACT",
                            "phone": "914-594-2150",
                            "email": "mitchell_cairo@nymc.edu"
                        },
                        {
                            "name": "Mitchell S. Cairo, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.07482,
                        "lon": -73.77513
                    }
                },
                {
                    "facility": "Nationwide Children's Hosptial",
                    "status": "RECRUITING",
                    "city": "Columbus",
                    "state": "Ohio",
                    "zip": "43205",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Dean Lee, MD, PhD",
                            "role": "CONTACT",
                            "phone": "614-722-3550",
                            "email": "Dean.Lee@nationwidechildrens.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.96118,
                        "lon": -82.99879
                    }
                },
                {
                    "facility": "Children's Hospital of Pennsylvania",
                    "status": "RECRUITING",
                    "city": "Philadelphia",
                    "state": "Pennsylvania",
                    "zip": "19104",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Nancy Bunin, MD",
                            "role": "CONTACT",
                            "phone": "215-590-2255",
                            "email": "buninn@email.chop.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.95233,
                        "lon": -75.16379
                    }
                },
                {
                    "facility": "Medical College of Wisconsin/Children's Hospital of Wisconsin",
                    "status": "RECRUITING",
                    "city": "Milwaukee",
                    "state": "Wisconsin",
                    "zip": "53226",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Julie A Talano, MD",
                            "role": "CONTACT",
                            "phone": "414-955-4185",
                            "email": "jtalano@mcw.edu"
                        },
                        {
                            "name": "Meredith Beversdorf, RN",
                            "role": "CONTACT",
                            "phone": "(414) 266-5891",
                            "email": "mbeversdorf@mcw.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 43.0389,
                        "lon": -87.90647
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "UNDECIDED"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000007239",
                    "term": "Infections"
                },
                {
                    "id": "D000003141",
                    "term": "Communicable Diseases"
                },
                {
                    "id": "D000020031",
                    "term": "Epstein-Barr Virus Infections"
                },
                {
                    "id": "D000081207",
                    "term": "Primary Immunodeficiency Diseases"
                },
                {
                    "id": "D000007153",
                    "term": "Immunologic Deficiency Syndromes"
                }
            ],
            "ancestors": [
                {
                    "id": "D000020969",
                    "term": "Disease Attributes"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                },
                {
                    "id": "D000014777",
                    "term": "Virus Diseases"
                },
                {
                    "id": "D000006566",
                    "term": "Herpesviridae Infections"
                },
                {
                    "id": "D000004266",
                    "term": "DNA Virus Infections"
                },
                {
                    "id": "D000014412",
                    "term": "Tumor Virus Infections"
                },
                {
                    "id": "D000007154",
                    "term": "Immune System Diseases"
                },
                {
                    "id": "D000030342",
                    "term": "Genetic Diseases, Inborn"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M10283",
                    "name": "Infections",
                    "asFound": "Infection",
                    "relevance": "HIGH"
                },
                {
                    "id": "M6368",
                    "name": "Communicable Diseases",
                    "asFound": "Infection",
                    "relevance": "HIGH"
                },
                {
                    "id": "M2285",
                    "name": "Primary Immunodeficiency Diseases",
                    "asFound": "Primary Immune Deficiency Disorder",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10199",
                    "name": "Immunologic Deficiency Syndromes",
                    "asFound": "Immune Deficiency Disorder",
                    "relevance": "HIGH"
                },
                {
                    "id": "M17522",
                    "name": "Virus Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M21881",
                    "name": "Epstein-Barr Virus Infections",
                    "asFound": "Epstein-Barr Virus Infections",
                    "relevance": "HIGH"
                },
                {
                    "id": "M16355",
                    "name": "Syndrome",
                    "relevance": "LOW"
                },
                {
                    "id": "M22700",
                    "name": "Disease Attributes",
                    "relevance": "LOW"
                },
                {
                    "id": "M9643",
                    "name": "Herpesviridae Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M7442",
                    "name": "DNA Virus Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M17162",
                    "name": "Tumor Virus Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M10200",
                    "name": "Immune System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M23686",
                    "name": "Genetic Diseases, Inborn",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC01",
                    "name": "Infections"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "BC16",
                    "name": "Diseases and Abnormalities at or Before Birth"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                }
            ]
        }
    },
    "hasResults": false
}